Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of antiviral and central nervous system drugs. Its fluorinated pyrrolidine structure enhances metabolic stability and bioavailability, making it valuable in medicinal chemistry for designing enzyme inhibitors and receptor modulators. Commonly employed in the preparation of protease inhibitors and kinase inhibitors due to its ability to mimic peptide bonds and influence binding affinity.